CD33 TRAILBody (Trio Pharmaceuticals)

N/A

Report date: 2024/08/07 13:51:05

Base Information

Drug NameCD33 TRAILBody (Trio Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionMyeloid cell surface antigen CD33 modulators
TargetsMyeloid cell surface antigen CD33
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTRIO Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTRIO Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A